Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationFrom July 2025
The call for application for phase 2 of the AI Airlock is now open.
AI breakthroughs drive expansion of ‘Airlock’ testing programme to support AI-powered healthcare innovation
New MHRA CEO puts safety, accelerated access and innovation at the centre of agency’s refreshed strategic direction.
Since, April 2024, the MHRA has been using Lorenz DocuBridge for eCTD management in product license submissions. This change is part of the modernisation of the MHRA’s Legacy Systems and is one of the initial tools launched in the RegulatoryConnect programme.
New Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical device manufacturers to proactively monitor the safety and performance of their products once on the market.
The newsletter for patients, consumers and healthcare professionals
Millions will take part in clinical trials under the 10 Year Health Plan which will speed up clinical research.
Comments Published
The RQA GPvP Committee have collated relevant pharmacovigilance news and will share quarterly.